BioLineRx (BLRX) Debt Ratio: 2023-2025
Historic Debt Ratio for BioLineRx (BLRX) over the last 2 years, with Jun 2025 value amounting to 0.26.
- BioLineRx's Debt Ratio fell 43.23% to 0.26 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.26, marking a year-over-year decrease of 43.23%. This contributed to the annual value of 0.35 for FY2024, which is 125.91% up from last year.
- BioLineRx's Debt Ratio amounted to 0.26 in Q2 2025, which was down 8.58% from 0.28 recorded in Q1 2025.
- In the past 5 years, BioLineRx's Debt Ratio ranged from a high of 0.53 in Q3 2024 and a low of 0.15 during Q4 2023.
- Its 3-year average for Debt Ratio is 0.28, with a median of 0.24 in 2023.
- Per our database at Business Quant, BioLineRx's Debt Ratio soared by 141.54% in 2024 and then crashed by 43.23% in 2025.
- BioLineRx's Debt Ratio (Quarterly) stood at 0.15 in 2023, then surged by 125.91% to 0.35 in 2024, then tumbled by 43.23% to 0.26 in 2025.
- Its Debt Ratio stands at 0.26 for Q2 2025, versus 0.28 for Q1 2025 and 0.35 for Q4 2024.